Where does Shanxi Jinbo Bio-pharmaceutical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shanxi Jinbo Bio-pharmaceutical Co., Ltd. ranks #37,450 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Shanxi Jinbo Bio-pharmaceutical Co., Ltd. hold?

Shanxi Jinbo Bio-pharmaceutical Co., Ltd. holds 7 US utility patents granted between 2022 and 2025, spanning 10 technology areas.

What is Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s Innovation Score?

Shanxi Jinbo Bio-pharmaceutical Co., Ltd. has an Innovation Score of 47.1 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Shanxi Jinbo Bio-pharmaceutical Co., Ltd..

What does claim depth mean for Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s patents?

Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Shanxi Jinbo Bio-pharmaceutical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanxi Jinbo Bio-pharmaceutical Co., Ltd.

Q: What technology areas does Shanxi Jinbo Bio-pharmaceutical Co., Ltd. focus on?

Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 6 patents, ranking #1,557 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shanxi ranks #37,450 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.

#37,450
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.1/100): 14.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R37450 · Foreign Corporation #37,450 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #37,450/49,997
PHOTO-FINISH Shanghai Qiyu…
CPC-FOCUS C12N · 10 areas
INNOV-PAR 47.1/100
CLAIMS-RICH 14.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Shanghai Qiyu Communication Technology Service Center (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shanxi’s 47.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (15%) Velocity 20.0 pts (42%) Breadth 11.2 pts (24%) Claim depth 8.7 pts (18%)

Qualcomm Incorporated · highest

85
Areva NP · near

47
Shanxi Jinbo… · this assignee

47
The Hershey · near

47
Université Paris—Est… · near

47
Videojet · near

47
3D Lighting… · lowest

7

What this shows Shanxi's Innovation Score is 47.1/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Shanxi?

Each dot is one of Shanxi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanxi’s own 14.6 claims/patent is ABOVE the 10.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Shanxi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shanxi's grants concentrate

Shanxi Jinbo Bio-pharmaceutical Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 85.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). By volume, Shanxi sits between Shanghai Qiyu Communication Technology Service Center and Shenyang Research Institute OF Chemical Industry Co., Ltd..

Shanxi's three-year grant acceleration

Shanxi Jinbo Bio-pharmaceutical Co., Ltd. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Shanghai Qiyu Com…

7
Shanghai Synergy…

7
Shanghai XIN QI T…

7
Shanghai Xintang…

7
Shawhan Biomedical

7
Shelfbucks

7
Shen Zhen Aimson…

7
Shenyang Research…

7
Shanxi Jinbo Bio-… ◀

7

What this shows Shanxi holds 7 patents at rank #37,373, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shanxi

By rank, the assignees closest to #37,373 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Shanxi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shanxi, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Shanxi ranks #1,557 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Université Paris—Est Créteil Val de Marne 47 The Hershey Company 47 Areva NP 47 Videojet Technologies Inc. 47

Shanxi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Shanxi Jinbo Bio-pharmaceutical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	14.3%
2023	1	14.3%
2024	1	14.3%
2025partial year	4	57.1%

Which technologies does Shanxi Jinbo Bio-pharmaceutical Co., Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07K - Peptides 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.

Shanxi Jinbo Bio-pharmaceutical Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 85.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #37,450 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shanxi Jinbo Bio-pharmaceutical Co., Ltd. against Shanghai Qiyu Communication Technology Service Center, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.